Kathryn E. Falberg - May 21, 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Director
Signature
/s/ Stephen Dang, Attorney-in-Fact
Stock symbol
NUVB
Transactions as of
May 21, 2025
Transactions value $
$0
Form type
4
Date filed
5/23/2025, 04:05 PM
Previous filing
Apr 17, 2025
Next filing
May 29, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FALBERG KATHRYN E Director C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK /s/ Stephen Dang, Attorney-in-Fact 2025-05-23 0001206977

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +293K $0.00 293K May 21, 2025 Class A Common Stock 293K $2.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.